THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM

The PCCTC was formed to address critically unmet needs in prostate cancer. Our mission is to design, implement, and complete process driven clinical trials, translating scientific discoveries to improved standards of care.

Learn More +

The PCCTC is changing how prostate cancer drugs are developed. Our unique infrastructure facilitates project co-development between investigators, clinical research sites and industry partners.

View Our Services

Expertise

Internationally recognized leaders in the field, PCCTC investigators come from the nation’s top academic medical centers where they are actively engaged in world class science through cutting-edge translational prostate cancer research.

Our Participating Clinical Research Sites

Recent News +++

PCCTC Medical Director Michael Morris, MD Profiled, “A Triumph Against Prostate Cancer”

Press Releases by PCCTC November 28, 2022

New technology provides a major step forward in diagnosing and treating prostate cancer.

Learn More

JUST PUBLISHED—IRONMAN: A Novel International Registry of Men with Advanced Prostate Cancer

Press Releases by PCCTC November 8, 2022

A new manuscript published in JCO Global Oncology describes the PCCTC managed IRONMAN Regi...

Learn More

The PCCTC at ASCO22

Press Releases by PCCTC June 3, 2022

More than 40,000 oncology professionals from around the world will convene at the annual A...

Learn More

Lantheus Collaborates with The Prostate Cancer Clinical Trial Consortium (PCCTC) To Advance AI-Enabled Imaging Biomarkers in Prostate Cancer

Press Releases by PCCTC January 27, 2022

NORTH BILLERICA, MA, January 27, 2022 – Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus...

Learn More

Genetic Testing for Prostate Cancer: Considerations for Practice Virtual Genetics Board

Press Releases by PCCTC December 8, 2021

The Prostate Cancer Clinical Trials Consortium (PCCTC) Genetics Germline Working Group is ...

Learn More
View More News +

Follow Us

RT @urotoday: Mark your Calendars! The #ProstateCancer #PatientSummit is taking place in #SanDiego, Jan 28, 2023, highlighting resources to…
Led by Dr @xiaoweimd (@DanaFarber), our study of nivolumab + docetaxel + ADT is enrolling eligible patients with me… https://t.co/gN2ZTe5Fpd
PCCTC investigator Dr @Daniel_J_George of @DukeGUCancer discusses antibody drug conjugates in #prostatecancer via… https://t.co/VpRMz7F00W

Join our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…

2018-23944 Clinical Data Manager, Prostate Cancer Clinical Trials Consortium (PCCTC) | Memorial Sloan Kettering Cancer Center Careers

careers.mskcc.org

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.